aTyr Pharma, Inc. (ATYR)
3.82
+0.13
(+3.52%)
USD |
NASDAQ |
Nov 20, 16:00
3.80
-0.02
(-0.52%)
After-Hours: 20:00
aTyr Pharma Total Liabilities (Quarterly) : 26.01M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 26.01M |
| June 30, 2026 | 21.23M |
| March 31, 2026 | 21.91M |
| December 31, 2025 | 26.88M |
| September 30, 2025 | 26.61M |
| June 30, 2025 | 26.88M |
| March 31, 2025 | 22.38M |
| December 31, 2024 | 28.22M |
| September 30, 2024 | 26.48M |
| June 30, 2024 | 24.52M |
| March 31, 2024 | 28.97M |
| December 31, 2023 | 31.60M |
| September 30, 2023 | 26.87M |
| June 30, 2023 | 26.70M |
| March 31, 2023 | 27.14M |
| December 31, 2022 | 24.50M |
| September 30, 2022 | 19.05M |
| June 30, 2022 | 9.558M |
| March 31, 2022 | 6.402M |
| December 31, 2021 | 6.411M |
| September 30, 2021 | 6.477M |
| June 30, 2021 | 8.19M |
| March 31, 2021 | 5.596M |
| December 31, 2020 | 7.242M |
| Date | Value |
|---|---|
| September 30, 2020 | 9.638M |
| June 30, 2020 | 11.62M |
| March 31, 2020 | 12.48M |
| December 31, 2019 | 15.16M |
| September 30, 2019 | 17.01M |
| June 30, 2019 | 18.54M |
| March 31, 2019 | 20.43M |
| December 31, 2018 | 19.10M |
| September 30, 2018 | 20.79M |
| June 30, 2018 | 22.93M |
| March 31, 2018 | 23.97M |
| December 31, 2017 | 25.11M |
| September 30, 2017 | 22.20M |
| June 30, 2017 | 21.44M |
| March 31, 2017 | 15.03M |
| December 31, 2016 | 17.72M |
| September 30, 2016 | 11.94M |
| June 30, 2016 | 13.92M |
| March 31, 2016 | 14.69M |
| December 31, 2015 | 14.62M |
| September 30, 2015 | 12.21M |
| June 30, 2015 | 13.74M |
| March 31, 2015 | 16.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
| Arrowhead Pharmaceuticals, Inc. | 1.759B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.81M |
| Shareholders Equity (Quarterly) | 33.98M |
| Debt to Equity Ratio | 0.3213 |
| Current Ratio | 3.047 |
| Net Debt Paydown Yield | 1.16% |